Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07456930 · ClinicalTrials.gov registry record
Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment
A clinical trial, sponsored by Tools4Patient.
- Not yet
- Registry status
- 295
- Enrollment target
NCT07456930 is a clinical trial that has not yet begun recruiting, run by Tools4Patient. The registered enrollment target is 295 participants.
The verdict
NCT07456930 has not yet begun recruiting, sponsored by Tools4Patient.
- NOT YET RECRUITING
- Registry status
- 295 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn whether the Compl-AI model can accurately predict who is likely to stop their medication for opioid use disorder (MOUD) early in adults receiving real-world treatment for opioid use disorder (OUD). The main questions it aims to answer is: can the model accurately predict early discontinuation of MOUD? Because this study has no comparison groups, all participants receive their usual MOUD as part of routine care. Researchers will observe how participants engage with treatment and how well Compl-AI predicts their outcomes. Participants will complete 4 visits, including a questionnaire about personal experiences during first visit and questions about their substance use and treatment history. During the monthly study visits, the researchers will record in particular the attendance at MOUD medication visits, the medication adherence and any treatment discontinuation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07456930
The ClinicalTrials.gov registry entry for NCT07456930 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 295 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tools4Patient, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07456930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07456930 about?
NCT07456930 is a clinical study titled "Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment". The goal of this observational study is to learn whether the Compl-AI model can accurately predict who is likely to stop their medication for opioid use disorder (MOUD) early in adults receiving real-world treatment for opioid use disorder (OUD). The main questions it aims to answer is: can the mo...
What is the current status of trial NCT07456930?
This trial is currently not yet recruiting. The enrollment target is 295 participants. The study started on 2026-06-01. Estimated completion is 2026-12.
Who is sponsoring clinical trial NCT07456930?
This trial is sponsored by Tools4Patient, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.